Key result
Restenosis following percutaneous transluminal coronary angioplasty occurs in approximately one-third of patients, and no treatment has yet been shown to significantly reduce its rate.
Population
Patients undergoing percutaneous transluminal coronary angioplasty
Design
Review
Authors
Loading...
Restenosis remains a major post-PTCA limitation without effective therapies; leaves open the search for preventive strategies.
Restenosis remains a major limitation of coronary angioplasty, with no effective treatments currently available to significantly reduce its occurrence.
Karas et al. (1991) conducted a review in Restenosis following coronary angioplasty. Restenosis following percutaneous transluminal coronary angioplasty occurs in approximately one-third of patients, and no treatment has yet been shown to significantly reduce its rate.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: